Evaluating DyNamic Myocardial Blood Flow QUantitation As a Cost Effective Care ModeL for DiabEtic Patients With Coronary Artery DiSease
NCT05343884 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2022-04-25
Summary
This will be a prospective randomized clinical trial comprising of n=300 diabetic patients, randomized to either dynamic (n=150) or conventional MPI (n=150) strategy. Healthcare resources utilization of each patient will be tracked. Patients will be followed up for short term outcomes and for long term outcomes.
Conditions
Interventions
- RADIATION
-
Myocardial perfusion imaging
Myocardial perfusion imaging
Sponsors & Collaborators
-
National Medical Research Council (NMRC), Singapore
collaborator OTHER_GOV -
National Heart Centre Singapore
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-15
- Primary Completion
- 2025-03-31
- Completion
- 2026-03-31
Countries
- Singapore
Study Locations
More Related Trials
-
Cell Therapy In Dilated Cardiomyopathy
NCT00333827 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart Failure
NCT06137430 ·Status: NOT_YET_RECRUITING
-
Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling in Diabetic Patients
NCT07186153 ·Status: NOT_YET_RECRUITING
-
A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction
NCT04840914 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
NCT00050076 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI
NCT07138508 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial
NCT04304560 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease
NCT03351738 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure
NCT02135835 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Efficacy on Cardiac Remodeling of Recombinant Human Neuregulin-1 in Stable Chronic Systolic Heart Failure Patients
NCT01439893 ·Status: TERMINATED ·Phase: PHASE3
-
Early Administration of Ivabradine in Children With Heart Failure
NCT04405804 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Dapagliflozin on VT in Patients With Heart Failure.
NCT05550441 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
NCT00259038 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Nicorandil on Left Ventricular Myocardial Strain in Patients With Coronary Chronic Total Occlusion
NCT05087797 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
NCT02344641 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
NCT00799435 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction
NCT06946095 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
NCT05305911 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction
NCT05045274 ·Status: UNKNOWN ·Phase: NA
-
Hyperemic Efficacy of IV Adenosine in HFrEF
NCT03235700 ·Status: UNKNOWN ·Phase: NA
-
Concentrations of Amiodarone in Fat Tissue During Chronic Treatment
NCT00313443 ·Status: COMPLETED ·Phase: PHASE4
-
SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand)
NCT04198883 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Ubiquinol Treatment in Patients With Heart Failure and Preserved Ejection Fraction
NCT02779634 ·Status: UNKNOWN ·Phase: PHASE2
-
Digitalis Investigation Group (DIG)
NCT00000476 ·Status: COMPLETED ·Phase: PHASE3
-
Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
NCT04697485 ·Status: WITHDRAWN ·Phase: PHASE4